Relief Therapeutics Holding AG (RLFTF)

[aGuyUS]

TODAYS PULLBACK is A tale of two DRUGS

there is an article in switzerland that's caused a stir as we can see this morning... it has the following quote

https://www.fuw.ch/article/reliefs-stunde-der-wahrheit-naht/

"However, two bank analysts had warned on an earlier occasion that such results with relatively few participants are often deceptive. One of them, Olav Zilian from Mirabaud Securities, even recommended the shares for sale on Monday. The reason is that a phase II study for a competing product is being canceled. PhaseBio's pemziviptadil showed no efficacy in the first 25 patients. "Based on the molecular profile of the two active ingredients, it seems likely to us that the active ingredient from Relief Therapeutics will also struggle to show effectiveness," writes Zilian in the bank's newsletter"


Now if you believe RLF 100 is the same as Phasebio's drug, which we kno it is not, then the selling would make sense but we're informed investors. But for the ones that are not as informed and have held shares and are nervous, We see what's happening now.

We know that there is a huge difference between Phase bio's drug and RLF-100...

That RLF 100 Acts directly on VPAC1 and Phasebio's drug on VPAC2 receptors, The reason being is the Method of Action on the two drugs are different when acting on the Two different receptors. This is a sell off of no merit in my opinion

I am long and bullish on RLFTF